Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (11-20 of 308) with videos related to

Pageof 31
Sort By:
Antiviral Research|July 31, 2024
Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis BZhe Xie, Ulrike Protzer
Gastroenterology|October 28, 2018
Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV InfectionAdam J Gehring, Ulrike Protzer
Viruses|November 26, 2020
Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing DataStoyan Velkov, Ulrike Protzer, Thomas Michler
Digestive Diseases (Basel, Switzerland)|September 7, 2011
Immune control of hepatitis B virusTanja Bauer, Martin Sprinzl, Ulrike Protzer
Journal of Virology|August 20, 2010
Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virusSilke Arzberger, Marianna Hösel, Ulrike Protzer
Zeitschrift Fur Gastroenterologie|January 15, 2019
Towards curative therapy of chronic viral hepatitisRalf Bartenschlager, Stephan Urban, Ulrike Protzer
Current Opinion in Virology|May 12, 2018
Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccinationClaudia Dembek, Ulrike Protzer, Michael Roggendorf
Methods in Molecular Medicine|February 6, 2004
Construction of recombinant adenoviruses that produce infectious hepatitis B virusMartin Sprinzl, Jérôme Dumortier, Ulrike Protzer
Antiviral Research|December 26, 2012
Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytesJulie Lucifora, Knud Esser, Ulrike Protzer
Current Opinion in Virology|April 24, 2017
Novel viral and host targets to cure hepatitis BChunkyu Ko, Thomas Michler, Ulrike Protzer
Pageof 31

Showing results (11-20 of 308) with videos related to

Sort By:
Pageof 31
Antiviral Research|July 31, 2024
Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis BZhe Xie, Ulrike Protzer
Gastroenterology|October 28, 2018
Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV InfectionAdam J Gehring, Ulrike Protzer
Viruses|November 26, 2020
Global Occurrence of Clinically Relevant Hepatitis B Virus Variants as Found by Analysis of Publicly Available Sequencing DataStoyan Velkov, Ulrike Protzer, Thomas Michler
Digestive Diseases (Basel, Switzerland)|September 7, 2011
Immune control of hepatitis B virusTanja Bauer, Martin Sprinzl, Ulrike Protzer
Journal of Virology|August 20, 2010
Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virusSilke Arzberger, Marianna Hösel, Ulrike Protzer
Zeitschrift Fur Gastroenterologie|January 15, 2019
Towards curative therapy of chronic viral hepatitisRalf Bartenschlager, Stephan Urban, Ulrike Protzer
Current Opinion in Virology|May 12, 2018
Overcoming immune tolerance in chronic hepatitis B by therapeutic vaccinationClaudia Dembek, Ulrike Protzer, Michael Roggendorf
Methods in Molecular Medicine|February 6, 2004
Construction of recombinant adenoviruses that produce infectious hepatitis B virusMartin Sprinzl, Jérôme Dumortier, Ulrike Protzer
Antiviral Research|December 26, 2012
Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytesJulie Lucifora, Knud Esser, Ulrike Protzer
Current Opinion in Virology|April 24, 2017
Novel viral and host targets to cure hepatitis BChunkyu Ko, Thomas Michler, Ulrike Protzer
Pageof 31